Dr. Miller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1400 MCKEAN ROAD
Spring House, PA 19477
Summary
- I am a Senior Vice President & Global Head of Translational Science & Medicine (TSM), Research & Development in the Immunology Therapeutic Area at Johnson & Johnson (J&J) Innovative Medicine, where I lead the TSM Organization, a team of talented, experienced and dedicated MD/PhD clinicians and scientists in Translational Science (research, discovery and biomarkers) and Translational Medicine (clinical trials and research) of drug development by incorporating cutting-edge science and technologies across the end-to-end portfolio for the Immunology Therapeutic Area’s four Disease Area Strongholds: Immunodermatology, Rheumatology, Gastroenterology and Autoantibody/Maternal Fetal Immunology, which include specialty and rare/orphan diseases
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Dermatology, 2000 - 2005
- State University of New York Downstate Medical Center College of MedicineClass of 2000
- Johns Hopkins UniversityB.A., Biology, 1990 - 1994
Certifications & Licensure
- CA State Medical License 2002 - 2026
- MD State Medical License 2012 - 2025
- PA State Medical License 2021 - 2024
- FL State Medical License 1973 - 2018
- KY State Medical License 1989 - 2017
- SC State Medical License 1982 - 2017
- IN State Medical License 1993 - 2013
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Second Place Winner UCLA Department of Medicine Research Day, 2008
- California Award Dermatologic Research Foundation, 2007
- Stein-Oppenheimer Endowment Fund Award UCLA, 2006
- Join now to see all
Publications & Presentations
PubMed
- 36 citationsOral-Only Linezolid-Rifampin Is Highly Effective Compared with Other Antibiotics for Periprosthetic Joint Infection: Study of a Mouse Model.John M. Thompson, Vikram Saini, Alyssa G. Ashbaugh, Robert J. Miller, Alvaro A. Ordonez
The Journal of Bone and Joint Surgery. American Volume. 2017-04-19 - 15 citationsPreclinical Evaluation of Photoacoustic Imaging as a Novel Noninvasive Approach to Detect an Orthopaedic Implant Infection.Yu Wang, John M. Thompson, Alyssa G. Ashbaugh, Pavlo Khodakivskyi, Ghyslain Budin
The Journal of the American Academy of Orthopaedic Surgeons. 2017-02-01 - 17 citationsCombination Prophylactic Therapy with Rifampin Increases Efficacy against an Experimental Staphylococcus epidermidis Subcutaneous Implant-Related InfectionAlexandra I. Stavrakis, Jared A. Niska, Jonathan H. Shahbazian, Amanda H. Loftin, Romela Irene Ramos
Antimicrobial Agents and Chemotherapy. 2014-04-01
Journal Articles
- Combined in Vivo Optical and MuCT Imaging to Monitor Infection, Inflammation and Bone Anatomy in an Orthopaedic Implant Infection in MiceBernthal, NM, Taylor, BN, Meganck, JA, Wang, Y, Shahbazian, JH, Niska, JA, Francis, KP, Miller, LS, Journal of Visualized Experiments, 1/1/2014
- Combination Prophylactic Therapy with Rifampin has Increased Efficacy Against an Experimental Staphylococcus epidermidis Subcutaneous Implant-Related InfectionStavrakis, AI, Niska, JA, Shahbazian, JH, Loftin, AH, Ramos, RI, Billi, F, Francis, KP, Otto, M, Bernthal, NM, Uslan, DZ, Miller, LS, Antimicrobial Agents and Chemotherapy, 1/1/2014
- Vancomycin-Rifampin Combination Therapy Has Enhanced Efficacy against an Experimental Staphylococcus aureus Prosthetic Joint InfectionNiska, JA, Shahbazian, JH, Ramos, RI, Francis, KP, Miller, LS, Antimicrobial Agents and Chemotherapy, 1/1/2013
- Join now to see all
Books/Book Chapters
Lectures
- Structure and Function of the Skin: Cancer, Immunity and InflammationAmerican Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/1/2019
- Noninvasive in Vivo Optical and Anatomical Imaging in Mice Provides Novel Insights into the Pathogenesis, Treatment and Diagnosis of S. Aureus InfectionsDivision of Bacterial, Parasitic, and Allergenic Products, Silver Spring, MD - 11/1/2014
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: